(GERN) Geron - Performance -72.3% in 12m
GERN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-23.40%
#45 in Peer-Group
Rel. Strength
4.31%
#7333 in Stock-Universe
Total Return 12m
-72.27%
#164 in Peer-Group
Total Return 5y
-34.00%
#51 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 4.99 USD |
| 52 Week Low | 1.18 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 26.09 |
| Buy/Sell Signal +-5 | -1.03 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: GERN (-72.3%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: GERN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GERN
| Total Return (including Dividends) | GERN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -14.29% | 3.15% | 4.01% |
| 3 Months | -4.35% | 17.08% | 17.14% |
| 12 Months | -72.27% | -11.14% | 13.46% |
| 5 Years | -34.00% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | GERN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -80.4% | 52.1% | 90.3% |
| 3 Months | 48.5% | 79.4% | 97.5% |
| 12 Months | -95.8% | -87.4% | 46.4% |
| 5 Years | 50.1% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th15.00 | -16.90% | -17.59% |
| 3 Month | %th20.00 | -18.30% | -18.35% |
| 12 Month | %th19.00 | -68.79% | -75.56% |
| 5 Years | %th76.00 | -15.43% | -68.97% |
FAQs
Does Geron (GERN) outperform the market?
No,
over the last 12 months GERN made -72.27%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months GERN made -4.35%, while XBI made 17.08%.
Performance Comparison GERN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
GERN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.1% | -18.3% | -63.6% | -86% |
| US NASDAQ 100 | QQQ | -4% | -18.5% | -65.6% | -86% |
| German DAX 40 | DAX | -4.5% | -15.5% | -75.7% | -103% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -5.3% | -18.8% | -68.1% | -91% |
| Hongkong Hang Seng | HSI | -5% | -17.1% | -85.6% | -107% |
| India NIFTY 50 | INDA | -2.8% | -13.5% | -64.1% | -69% |
| Brasil Bovespa | EWZ | 0.1% | -13.7% | -78.6% | -74% |
GERN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.7% | -16% | -66.9% | -96% |
| Consumer Discretionary | XLY | -5% | -17.6% | -55.9% | -90% |
| Consumer Staples | XLP | -2.1% | -14.2% | -62.7% | -80% |
| Energy | XLE | -7.1% | -18.4% | -56% | -74% |
| Financial | XLF | -2.7% | -16.9% | -65.9% | -98% |
| Health Care | XLV | -4.3% | -14.4% | -52.1% | -66% |
| Industrial | XLI | -4.5% | -18.7% | -69.4% | -96% |
| Materials | XLB | -4.8% | -18.8% | -64.2% | -76% |
| Real Estate | XLRE | -3.9% | -14.2% | -62.1% | -81% |
| Technology | XLK | -4% | -20.9% | -68.7% | -83% |
| Utilities | XLU | -4.2% | -16.9% | -67.6% | -92% |
| Aerospace & Defense | XAR | -4.8% | -21.1% | -83.6% | -121% |
| Biotech | XBI | -7.8% | -17.4% | -53.4% | -61% |
| Homebuilder | XHB | -7.2% | -23.1% | -57% | -71% |
| Retail | XRT | -4.1% | -17.5% | -58.8% | -79% |
GERN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -4.7% | -17.6% | -49.7% | -68% |
| Natural Gas | UNG | -2.4% | -7.8% | -37.6% | -70% |
| Gold | GLD | -4.2% | -14.5% | -81.5% | -111% |
| Silver | SLV | -8.4% | -20.6% | -85.6% | -94% |
| Copper | CPER | -14.4% | -29.3% | -83.1% | -96% |
GERN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -3.2% | -14.3% | -58.3% | -68% |
| iShares High Yield Corp. Bond | HYG | -3.6% | -15.4% | -60.6% | -81% |